US9072861B2 - Methods and devices for delivering or delaying lipids within a duodenum - Google Patents

Methods and devices for delivering or delaying lipids within a duodenum Download PDF

Info

Publication number
US9072861B2
US9072861B2 US13769097 US201313769097A US9072861B2 US 9072861 B2 US9072861 B2 US 9072861B2 US 13769097 US13769097 US 13769097 US 201313769097 A US201313769097 A US 201313769097A US 9072861 B2 US9072861 B2 US 9072861B2
Authority
US
Grant status
Grant
Patent type
Prior art keywords
flow reduction
reduction element
flow
device
spine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13769097
Other versions
US20130178782A1 (en )
Inventor
James T. McKinley
Zhenyong Keck
Fiona M. Sander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endosphere Inc
Original Assignee
Endosphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • A61F5/0079Pyloric or esophageal obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliances for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another

Abstract

Devices and methods described include a flow reduction device adapted and configured for use within the duodenum of a mammal having a spine, a first atraumatic feature, a second atraumatic feature, and a flow reduction element having a proximal end, a distal end, an interior portion, an exterior portion and a variable porosity between the proximal end and the distal end. One aspect of the device includes a spine having a proximal end and a distal end, an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine, and a flow reduction element positioned along the spine and having a variable porosity along its length.

Description

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/999,180, filed Jan. 31, 2011, entitled “METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM,” now Publication No. 2011-0137227, which is a 35 U.S.C. §371 national phase application of International Patent Application No. PCT/US2009/049586, filed Jul. 2, 2009, entitled “METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM,” now Publication No. WO 2010/003097, which claims the benefit of priority of U.S. Provisional Patent Application No. 61/077,579, filed Jul. 2, 2008, entitled “METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM” and is also a continuation-in-part of International Patent Application No. PCT/US2008/070226, filed Jul. 16, 2008, entitled “CONFORMATIONALLY-STABILIZED INTRALUMINAL DEVICE FOR MEDICAL APPLICATIONS,” now Publication No. WO 2009/012335 A1, the entirety of each of these applications is incorporated herein by reference in its entirety.

Various aspects of the design, function, deployment, operation and delivery of conformal flow reduction devices for use in the duodenum are described in the following related applications: U.S. Provisional Patent Application No. 60/950,071, filed Jul. 16, 2007, entitled “CONFORMATIONALLY-STABILIZED INTRALUMINAL DEVICE FOR MEDICAL APPLICATIONS,” now International Patent Application No. PCT/US2008/070226, filed Jul. 16, 2008, entitled “A CONFORMATIONALLY-STABILIZED INTRALUMINAL DEVICE FOR MEDICAL APPLICATIONS,” now Publication No. WO 2009/012335; U.S. patent application Ser. No. 10/999,410, filed Nov. 30, 2004, entitled “METHOD AND APPARATUS FOR REDUCING OBESITY,” now U.S. Pat. No. 7,931,693; U.S. patent application Ser. No. 11/300,283, filed Dec. 15, 2005, entitled “METHODS AND DEVICES TO CURB APPETITE AND/OR REDUCE FOOD INTAKE,” now U.S. Pat. No. 8,147,561; and U.S. patent application Ser. No. 11/807,107, filed May 25, 2007, entitled “METHODS AND DEVICES TO CURB APPETITE AND/OR REDUCE FOOD INTAKE,” now Publication No. 2007-0293885.

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

BACKGROUND

Obesity and type 2 diabetes are diseases of insufficient or deficient regulation. We know from human studies that the small intestine plays a critical role in both energy and glucose homeostasis: when the duodenum is exposed to lipids, appetite is diminished and native (liver) glucose production is down-regulated. Previously we have invented a device that can be implanted into the duodenum and remain in place; we have described devices and methods for slowing the passage of food through the duodenum to cause increased tissue-nutrient contact, thereby causing amplified hormonal signaling from the duodenum; and, we have invented methods and devices for delivering chemicals, drugs or other compounds to the duodenum.

What is needed are devices and/or methods for additional lipid uptake, delaying ingesta passage/prolonging ingesta contact, delivering or providing lipids or other appetite and glucose reducing nutrients and/or combinations of these characteristics.

SUMMARY OF THE DISCLOSURE

In one aspect of the present invention, there is provided a device adapted and configured for use within the duodenum of a mammal. The device has a spine having a proximal end and a distal end; an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine; and, positioned along the spine, a flow reduction element having variable porosity along its length. In one embodiment, the variable porosity of the flow reduction element is selected so that a portion of a flow over the proximal end of the flow reduction element flows into an interior portion of the flow reduction element. In one embodiment, the variable porosity of the flow reduction element is selected so that flow within an interior of the flow reduction element is at least partially inhibited from flowing through the distal portion of the variable porosity structure. In one embodiment, the proximal portion of the flow reduction element comprises a material, a mesh or a braid having a porosity or altered to provide a porosity selected to permit a flow into an interior portion of the flow reduction element. In one embodiment, the distal portion of the flow reduction element comprises a material, a mesh or a braid having a porosity or altered to provide a porosity selected to at least partially inhibit a flow from within an interior portion of the flow reduction element. In one embodiment, the length of the spine is selected so when the atraumatic feature is positioned in a stomach the flow reduction element is positioned on the spine and distal to a pylorus. In one embodiment, the length of the spine is selected so when the atraumatic feature is positioned in a stomach the distal end of the spine is in the fourth portion of the duodenum and the flow reduction element is positioned within a portion of the duodenum. In one embodiment, there is also a flow reduction element having a non-variable porosity along its length. In one embodiment, there is also a feature on the spine positioned to restrict movement of the flow reduction element relative to the spine.

In still another aspect of the present invention, there is provided a device adapted and configured for use within the duodenum of a mammal. The device has a spine with a length, a proximal end and a distal end; a first atraumatic feature positioned adjacent to the spine proximal end; a second atraumatic feature positioned adjacent to the spine distal end wherein the length of the spine is selected so that when the first atraumatic feature is in the stomach the second atraumatic feature is in the fourth portion of the duodenum; and a flow reduction element having a proximal end, a distal end, an interior portion, an exterior portion and a variable porosity between the proximal end and the distal end. In one embodiment, the porosity of the proximal end is selected to the allow flow to pass from the exterior portion to the interior portion. In one embodiment, the porosity of the distal end is selected to impede flow from the interior portion to the exterior portion. In one embodiment, the proximal portion is more porous than the distal portion. In one embodiment, the proximal end has a porous structure configured to permit flow into the interior portion and the distal end has a solid portion to retain material within the interior portion. In one embodiment, there is provided another flow reduction element between the proximal and distal ends of the spine. In one embodiment, the another flow reduction element has variable porosity between the proximal and distal ends of the flow reduction element. In one embodiment, the length of the spine is selected so that when the first atraumatic feature is positioned in a stomach the second atraumatic feature is positioned within the duodenum and adjacent to the first atraumatic feature. In one embodiment, the length of the spine is selected so that when the first atraumatic feature is positioned in a stomach the second atraumatic feature is positioned within the duodenum and in proximity to the ligament of Treitz.

In still another aspect, there is provided a method for adjusting the passage of ingesta through the duodenum of a mammal by placing the distal end of a flow reduction device in the duodenum of a mammal; placing the proximal end of the flow reduction device in a stomach of the mammal; expanding within the duodenum of the mammal a variable porosity flow reduction element supported by the flow reduction device; and directing at least a portion of the flow of ingesta through the duodenum through the proximal end of the variable porosity flow reduction element and into an interior portion of the variable porosity flow reduction element. In one embodiment, there is also provided a method retaining a portion of the ingesta within the interior portion of the variable porosity flow reduction element until the ingesta is pushed out of the interior portion by peristaltic action of the duodenum. In still another embodiment, there is provided a method of adjusting the passage of ingesta wherein the ingesta is pushed out of the interior portion by passing through a distal portion of the variable porosity flow reduction element. In still another alternative method for adjusting the passage of ingesta, the ingesta is pushed out of the interior portion by passing through the proximal portion and thereafter passing around the variable porosity flow reduction element.

In another aspect, the flow reduction elements positioned along the device backbone could be coated with, manufactured from or contain lipid-philic materials. For example, one or more of the flow reduction elements of the intraduodenal device could be manufactured from a lipid absorbing or adsorbing material. A flow reduction element manufactured in this way will attract and collect lipids from passing ingesta and hold the lipids for a period of time. The length of time that the lipids will remain attached to the flow reduction element will vary based on a number of factors. For example, the flow reduction element may exude the lipids as peristalsis continues to squeeze the device. The prolonged presence of and/or sustained release of lipids within the duodenum is believed to benefit and in some cases to increase hormonal regulation. It is to be appreciated that embodiments of the present invention provide prolonged presence of and/or sustained release of lipids within the duodenum through the use of one or more of: making flow reduction elements and/or other components of the flow reduction device (i.e., any of the components of FIG. 1 for example) at least partially or even completely from one or more lipid-philic materials; coating flow reduction elements and/or other components of the flow reduction device entirely or at least partially form lipid-philic materials; and/or placing within a flow reduction element, or attaching to a component of the flow reduction device an additional element or component formed from or at least partially coated with a lipid-philic material.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a prospective view of a device for use in the duodenum.

FIG. 2 is an enlarged view of one of the flow reduction elements of FIG. 1 showing the upper and lower portions of the element;

FIG. 2A is an enlarged view of a material used to provide variable porosity to a flow portion of a flow reduction element;

FIG. 2B is an enlarged view of a solid or semi permeable sheet where a pattern of holes are used to provided variable porosity to a portion of a flow reduction element;

FIG. 3 illustrates a flow reduction element embodiment where more of the flow reduction device is utilized for allowing flow through the use of a larger proximal portion having a more porous construction and a smaller distal portion having a less porous construction;

FIG. 4 illustrates a flow reduction element embodiment where more of the flow reduction device is utilized for preventing flow than for allowing flow through the use of a smaller proximal portion having a more porous construction and a larger distal portion having a less porous construction.

DETAILED DESCRIPTION

The present application relates to methods and devices for providing a sense of fullness/satiety and/or glucose production inhibition. The devices and methods described herein provide for additional lipid presence in the duodenum by delaying ingesta passage/prolonging ingesta contact, delivering or providing lipids or other satiety and/or glucose reducing nutrients and/or combinations thereof.

Lipids can be generally defined as substances such as a fat, oil or wax that dissolve in alcohol but not in water. Lipids contain carbon, hydrogen and oxygen but have far less oxygen proportionally than carbohydrates. They serve as a source of fuel and are an important constituent of the structure of cells. As used herein, lipids refer to any of fatty acids, glycerides, complex lipids and nonglycerides. Fatty acids include both saturated and unsaturated. Glycerides include, for example, neutral phosphoglycerides. Complex lipids are lipids complexed with another type of chemical compound and include, for example, lipoproteins, phospholipids and glycolipids. Nonglycerides include, for example, sphingolipds, steroids and waxes.

Because most ingesta contain lipids, it is believed that the methods and devices described herein for prolonging lipid residence time, delaying lipid passage and/or providing lipids would enhance the operating characteristics of a duodenal positioned flow reduction device, such as those described in the related applications. In other words, the methods and devices described herein not only slow the passage of food but may also detain or delay the passage of food. The delay or detention may allow for prolonged nutrient release and aid in achieving health objectives. Additionally or alternatively, the devices and methods described herein may also provide for active introduction of lipids into the duodenum.

Catch and hold food, some of which is lipid. By using flow reduction bulges along the spine of the device pictured in FIG. 1, ingesta can be caught and held temporarily. The mesh bulges may have a more open structure on the end from which nutrients arrive from the stomach and smaller openings on the end from which nutrients depart as one way to hold nutrients longer. Alternatively, the spheres could themselves become ‘buckets’ in which food is captured and retained. The bucket may be provided by having a solid bottom portion so that chyme entering remains in the bottom of the bucket until pushed out by peristaltic action or my movement of additional chyme to displace it.

The flow restriction devices may be any of a wide variety of shapes and dimensions as described in the incorporated patent applications. The adjustment of the flow characteristics of ingesta or chyme: (a) around the outside of a flow reduction element, (b) through a wall of a flow or portion of a flow reduction element and (c) retained within a flow reduction element may be accomplished in a number of ways. One way to adjust the flow characteristics within a flow regulated duodenum (i.e., a duodenum having a flow reduction device implanted within it) is through the porosity or flow characteristics of the flow reduction elements.

FIG. 1 illustrates a perspective view of a device 100 having a spine 105, a proximal end 110, a distal end 115, atraumatic features 120 on both the proximal and distal ends. A series of five flow reduction elements 130 are shown in position along the spine 105. There may be one or more features 135 on the spine to prevent unwanted proximal or distal movement of the flow reduction elements 130 along the spine 105. The flow reduction elements 130 are shown in a deployed configuration as they would be in use within the duodenum. In the most basic form, one or more of the flow reduction elements may be formed from a material or materials with porosity characteristics that adjust the flow characteristics of chyme or ingesta flow relative to the material and the flow reduction element.

As shown in FIG. 1, the device 100 is orientated as it would be implanted with the proximal end 110 in the stomach and the distal end 115 in the duodenum near the ligament of Trietz. Chyme/ingesta flow is from the proximal end 110 to the distal end 115 in FIG. 1. The more porous portion of the flow reduction element 140 will interact with the chyme first. Because of the porosity of this part of the flow reduction element, chyme will flow into the interior portion of the flow reduction element as well as around the flow reduction element. As peristaltic action in the duodenum continues to move the chyme, the portion inside of the flow reduction element is urged distally towards the portion of the flow reduction device that is less porous 150. Some of the chyme entering the flow reduction element portion 150 will be retained within the flow reduction element for some period of time based upon a number of factors such as how much the person has eaten and the porosity of this portion of the flow reduction element among others. As a result of the variable porosity of the structure of the flow reduction element, chyme enters but then is delayed in leaving the flow reduction element interior. It is believed that increasing the residence time of chyme within a flow reduction element will increase the time of interaction of the nutrients in that trapped portion and/or provide for an extended release of the lipids in the trapped portion of chyme. The retained food could be nutrient rich or lipid rich so that the prolonged exposure produces a sense of satiety and/or the inhibition of liver glucose production in the individual. One such mechanism that may be achieved or fostered by the embodiments described herein is described in “Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production” by Penny Y. T. Wang et al (Nature, Vol. 452:24 April 2008 doi:10.1038/nature06852).

The flow characteristics of the flow reduction element may be adjusted in a number of ways. FIG. 2 is an enlarged view of a flow reduction element 130 in FIG. 1. The flow reduction element is divided roughly in half with an upper portion 140 (the part to first contact with the flow of chyme) having a porosity that allows flow through it and into the interior of the flow reduction element. The bottom portion 150 of the flow reduction element is less porous or allows less flow of chyme from the interior of the flow reduction element. The variable porosity or flow characteristics of the flow reduction elements may be adjusted by selecting material with different sizes (FIG. 2A), shapes, construction, and/or filaments with different characteristics to enhance or diminish flow as needed for the upper or lower portions. The flow characteristics of a flow reduction element may be obtained by overlapping (i.e., joined or crossed without joining) filaments to form cells that will, to the desired degree, permit or impede chyme passage. Alternatively or additionally, the flow reduction element could be formed from a solid or semi-permeable sheet 160 with holes 161 formed in it as shown in FIG. 2B. The size, shape, pattern and distribution of the openings may be used to adjust the amount of relative flow through a flow reduction element.

The flow reduction element adjustment may also be accomplished by adjusting the relative amounts of the flow reduction element used for allowing flow (more porous 140) or preventing flow (less porous 150). FIG. 3 illustrates a flow reduction element embodiment where more of the flow reduction device is utilized for allowing flow than for preventing flow. In contrast, FIG. 4 illustrates a flow reduction element embodiment where more of the flow reduction device is utilized for preventing flow than for allowing flow.

The foregoing are merely examples. More than one flow allowing or more than one flow preventing zone or portion may be used in a flow reduction element. While the relative distribution of the flow zones has been generally perpendicular to the spine or flow within the duodenum, other orientations relative to the spine or the duodenum are possible depending upon the desired flow profile. Moreover, a device may have flow reduction elements having one or more flow adjustment zones, or no flow adjustment zones. The type of flow reduction elements and the flow characteristics of those flow reduction elements may be mixed within a flow reduction device depending upon the desired flow characteristics desired.

Other flow reduction element properties such as the shape and size of a reduction element, the relative size between reduction elements, the alignment or orientation of a reduction element to the central shaft or spine and other properties are further described in the incorporated applications and may also be adjusted to accomplish the nutrient delivery aspects described herein.

Alternatively, the flow reduction elements could also be configured to capture and hold a lipid For instance, to maintain a certain lipid level in the spheres, the patient could periodically swallow a lipid ‘pill’ or other form that engages the device and remains in place. The nutrient could also take the form of an extended release compound that releases an amount of the nutrient over time. The nutrient could also be mixed with another compound that is released when the patient consumes a releasing agent, such as before a meal or at a time of day prone to hunger pangs or higher than desired blood glucose levels. The releasing agent mixes with the nutrient compound mixture causing the release of nutrients, such as lipids, to aid in regulation of hunger and/or glucose.

In another aspect, the flow reduction device could be coated with, manufactured with or contain nutrients such as lipids or lipid-philic materials. For example, the flow reduction elements could be one or more bulges manufactured using lipid leaching materials; or the bulges could be manufactured with lipid-philic materials or a sponge like membrane inside the bulges or otherwise connected to the device backbone, that would absorb and distribute temporally lipids from passing ingesta to increase hormonal regulation.

In another aspect, the flow reduction elements positioned along the device backbone could be coated with, manufactured from or contain lipid-philic materials. For example, one or more of the flow reduction elements of the intraduodenal device could be manufactured from a lipid absorbing or adsorbing material. A flow reduction element manufactured in this way will attract and collect lipids from passing ingesta and hold the lipids for a period of time. The length of time that the lipids will remain attached to the flow reduction element will vary based on a number of factors. For example, the flow reduction element may exude the lipids as peristalsis continues to squeeze the device. The prolonged presence of and/or sustained release of lipids within the duodenum is believed to benefit and in some cases to increase hormonal regulation. It is to be appreciated that embodiments of the present invention provide prolonged presence of and/or sustained release of lipids within the duodenum through the use of one or more of: making flow reduction elements and/or other components of the flow reduction device (i.e., any of the components of FIG. 1 for example) at least partially or even completely from one or more lipid-philic materials; coating flow reduction elements and/or other components of the flow reduction device entirely or at least partially form lipid-philic materials; and/or placing within a flow reduction element, or attaching to a component of the flow reduction device an additional element or component formed from or at least partially coated with a lipid-philic material.,

The spine could be configured as a central tube with plural inlet/outlet ports in communication with a flow reduction element and/or the outside of the tube as described in the incorporated applications. Additionally or alternatively, a portion of the device itself, i.e.: the backbone or spine, could be hollow such that it could be filled with lipids that would leach out or otherwise be delivered to the duodenum. A nutrient reservoir may be implanted within the patient, within the flow reduction device or separately injected into the device during implantation, after insertion or periodically while the patient has the device inserted in his duodenum.

Additionally or alternatively, the lipid equipped hormonal regulatory device could be configured to release lipids on demand using an internal or external controller or device as described in U.S. patent application Ser. No. 11/807,107, filed May 25, 2007, entitled “METHODS AND DEVICES TO CURB APPETITE AND/OR REDUCE FOOD INTAKE,” now Publication No. 2007-0293885.

Claims (21)

What is claimed is:
1. A device adapted and configured for use within the duodenum of a mammal, comprising:
a spine having a proximal end and a distal end;
an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine; and
a flow reduction element positioned along the spine, the flow reduction element having a proximal portion with a first porosity and a distal portion with a second porosity, the first porosity greater than the second porosity such that the proximal portion permits a flow of chyme into an interior of the flow reduction element while the distal portion at least partially inhibits the flow of chyme out of the interior of the flow reduction element.
2. The device of claim 1 wherein the proximal portion of the flow reduction element comprises a material, a mesh or a braid having a porosity or altered to provide a porosity selected to permit the flow of chyme into the interior of the flow reduction element.
3. The device of claim 1 wherein the distal portion of the flow reduction element comprises a material, a mesh or a braid having a porosity or altered to provide a porosity selected to at least partially inhibit the flow of chyme from within the interior of the flow reduction element.
4. The device of claim 1 wherein the flow reduction element is positioned along the spine so when the atraumatic feature is positioned in a stomach the flow reduction element is positioned distal to a pylorus.
5. The device of claim 1 wherein a length of the spine is selected so when the atraumatic feature is positioned in a stomach the distal end of the spine is in the fourth portion of the duodenum and the flow reduction element is positioned within a portion of the duodenum.
6. The device of claim 1, wherein the flow reduction element is at least partially formed from a lipid-philic material.
7. The device of claim 1 wherein at least a portion of the interior of the flow reduction element is at least partially coated with a lipid-philic material.
8. The device of claim 1 wherein the flow reduction element is configured to deform in shape in response to a peristaltic action of the duodenum.
9. The device of claim 1 wherein at least a portion of an exterior of the flow reduction element is at least partially coated with a lipid-philic material.
10. The device of claim 1 further comprising:
a lipid-philic structure within the flow reduction element.
11. The device of claim 10 wherein the lipid-philic structure within the flow reduction element is attached to the spine.
12. The device of claim 10 wherein the lipid-philic structure within the flow reduction element is attached to the flow reduction element.
13. A device adapted and configured for use within the duodenum of a mammal, comprising:
a spine having a proximal end and a distal end;
a first atraumatic feature positioned adjacent to the spine proximal end;
a second atraumatic feature positioned adjacent to the spine distal end, wherein a length of the spine is selected so that when the first atraumatic feature is in a stomach the second atraumatic feature is in the duodenum; and
a plurality of flow reduction elements positioned along the spine, each flow reduction element having a proximal portion with a first porosity and a distal portion with a second porosity, the first porosity greater than the second porosity such that the proximal portion permits a flow of chyme into an interior portion of the flow reduction element while the distal portion at least partially inhibits the flow of chyme out of the interior portion of the flow reduction element.
14. The device of claim 13 wherein each flow reduction element is formed from a material selected to adjust the flow characteristics of chyme or ingesta relative to the material.
15. The device of claim 13 wherein the distal portion of each flow reduction element is a solid to retain the chyme within the interior portion.
16. The device of claim 13 wherein the plurality of flow reduction elements are configured to deform in shape in response to the peristaltic action of the duodenum.
17. The device of claim 13 wherein the length of the spine is selected so that when the first atraumatic feature is positioned in the stomach, the second atraumatic feature is positioned within the duodenum in proximity to the ligament of Treitz.
18. The device of claim 13 wherein at least a portion of an interior or an exterior of each flow reduction element is at least partially coated with a lipid-philic material.
19. The device of claim 13 further comprising:
a lipid-philic structure within each of the flow reduction elements.
20. The device of claim 19 wherein the lipid-philic structure within each flow reduction element is attached to the spine.
21. The device of claim 19 wherein the lipid-philic structure within each flow reduction element is attached to the flow reduction element.
US13769097 2004-02-26 2013-02-15 Methods and devices for delivering or delaying lipids within a duodenum Active 2028-11-04 US9072861B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US10999410 US7931693B2 (en) 2004-02-26 2004-11-30 Method and apparatus for reducing obesity
US11300283 US8147561B2 (en) 2004-02-26 2005-12-15 Methods and devices to curb appetite and/or reduce food intake
US11807107 US8585771B2 (en) 2004-02-26 2007-05-25 Methods and devices to curb appetite and/or to reduce food intake
US95007107 true 2007-07-16 2007-07-16
US7757908 true 2008-07-02 2008-07-02
PCT/US2008/070226 WO2009012335A1 (en) 2007-07-16 2008-07-16 A conformationally-stabilized intraluminal device for medical applications
PCT/US2009/049586 WO2010003097A3 (en) 2008-07-02 2009-07-02 Methods and devices for delivering or delaying lipids within a duodenum
US99918011 true 2011-01-31 2011-01-31
US13769097 US9072861B2 (en) 2004-11-30 2013-02-15 Methods and devices for delivering or delaying lipids within a duodenum

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13769097 US9072861B2 (en) 2004-11-30 2013-02-15 Methods and devices for delivering or delaying lipids within a duodenum
US14793454 US20150305906A1 (en) 2004-11-30 2015-07-07 Methods and devices for delivering or delaying lipids within a duodenum
US15384130 US20170156908A1 (en) 2004-11-30 2016-12-19 Methods and devices for delivering or delaying lipids within a duodenum

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2009/049586 Continuation WO2010003097A3 (en) 2007-07-16 2009-07-02 Methods and devices for delivering or delaying lipids within a duodenum
US12999180 Continuation US20110137227A1 (en) 2007-07-16 2009-07-02 Methods and devices for delivering or delaying lipids within a duodenum
US99918011 Continuation 2011-01-31 2011-01-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14793454 Continuation US20150305906A1 (en) 2004-02-26 2015-07-07 Methods and devices for delivering or delaying lipids within a duodenum

Publications (2)

Publication Number Publication Date
US20130178782A1 true US20130178782A1 (en) 2013-07-11
US9072861B2 true US9072861B2 (en) 2015-07-07

Family

ID=44114303

Family Applications (4)

Application Number Title Priority Date Filing Date
US12999180 Abandoned US20110137227A1 (en) 2007-07-16 2009-07-02 Methods and devices for delivering or delaying lipids within a duodenum
US13769097 Active 2028-11-04 US9072861B2 (en) 2004-02-26 2013-02-15 Methods and devices for delivering or delaying lipids within a duodenum
US14793454 Abandoned US20150305906A1 (en) 2004-02-26 2015-07-07 Methods and devices for delivering or delaying lipids within a duodenum
US15384130 Abandoned US20170156908A1 (en) 2004-02-26 2016-12-19 Methods and devices for delivering or delaying lipids within a duodenum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12999180 Abandoned US20110137227A1 (en) 2007-07-16 2009-07-02 Methods and devices for delivering or delaying lipids within a duodenum

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14793454 Abandoned US20150305906A1 (en) 2004-02-26 2015-07-07 Methods and devices for delivering or delaying lipids within a duodenum
US15384130 Abandoned US20170156908A1 (en) 2004-02-26 2016-12-19 Methods and devices for delivering or delaying lipids within a duodenum

Country Status (1)

Country Link
US (4) US20110137227A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140114228A1 (en) * 2004-02-26 2014-04-24 Kenneth F. Binmoeller Methods and devices to curb appetite and/or to reduce food intake
US20150305906A1 (en) * 2004-11-30 2015-10-29 James T. McKinley Methods and devices for delivering or delaying lipids within a duodenum

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US9060835B2 (en) * 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US9198791B2 (en) 2010-07-22 2015-12-01 Endobetix Ltd. Pancreaticobiliary diversion device
WO2015126872A1 (en) 2014-02-19 2015-08-27 Mcneil Nutritionals, Llc. Ingestible nutritional dose forms for inducing satiety

Citations (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773502A (en) 1953-12-21 1956-12-11 Arthur L Kaslow Device for treating alimentary tract
US3546961A (en) 1967-12-22 1970-12-15 Gen Electric Variable flexibility tether
US4133315A (en) 1976-12-27 1979-01-09 Berman Edward J Method and apparatus for reducing obesity
US4134405A (en) 1977-01-10 1979-01-16 Smit Julie A Catheter and intestine tube and method of using the same
US4315509A (en) 1977-01-10 1982-02-16 Smit Julie A Insertion and removal catheters and intestinal tubes for restricting absorption
US4416267A (en) 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4485805A (en) 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
US4501264A (en) 1978-06-02 1985-02-26 Rockey Arthur G Medical sleeve
US4648383A (en) 1985-01-11 1987-03-10 Angelchik Jean P Peroral apparatus for morbid obesity treatment
US4694827A (en) 1986-01-14 1987-09-22 Weiner Brian C Inflatable gastric device for treating obesity and method of using the same
WO1989000407A1 (en) 1987-07-21 1989-01-26 Thomas Vincent Taylor Apparatus for arrest of bleeding at a duodenal ulcer
JPH0115063B2 (en) 1983-12-09 1989-03-15 Hitachi Metals Ltd
US4878905A (en) 1986-02-07 1989-11-07 Blass Karl G Gastrointestinal module: a nonsurgical implant
US4899747A (en) 1981-12-10 1990-02-13 Garren Lloyd R Method and appartus for treating obesity
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
DE4012642A1 (en) 1990-04-20 1991-10-24 Wolf Gmbh Richard Therapy or surgical instrument - has pre-shaped balloons of different sizes inflated via endoscope etc.
US5084061A (en) 1987-09-25 1992-01-28 Gau Fred C Intragastric balloon with improved valve locating means
US5234454A (en) 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5259399A (en) 1992-03-02 1993-11-09 Alan Brown Device and method of causing weight loss using removable variable volume intragastric bladder
US5329942A (en) 1990-08-14 1994-07-19 Cook, Incorporated Method for filtering blood in a blood vessel of a patient
US5396880A (en) 1992-04-08 1995-03-14 Danek Medical, Inc. Endoscope for direct visualization of the spine and epidural space
US5439476A (en) 1993-02-04 1995-08-08 Trigonon, Inc. Inflatable laparoscopic retractor
US5484610A (en) 1991-01-02 1996-01-16 Macromed, Inc. pH and temperature sensitive terpolymers for oral drug delivery
US5597797A (en) 1990-06-07 1997-01-28 Genentech, Inc. Method for treatment or prevention of obesity
US5820584A (en) 1997-08-28 1998-10-13 Crabb; Jerry A. Duodenal insert and method of use
US5868141A (en) 1997-05-14 1999-02-09 Ellias; Yakub A. Endoscopic stomach insert for treating obesity and method for use
US6102922A (en) 1995-09-22 2000-08-15 Kirk Promotions Limited Surgical method and device for reducing the food intake of patient
US6160084A (en) 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6187330B1 (en) 1998-01-30 2001-02-13 Scios Inc. Controlled release delivery of peptide or protein
US6264700B1 (en) 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve
US6267988B1 (en) 1992-05-28 2001-07-31 James H. Meyer Composition and method for inducing satiety
US6281262B1 (en) 1998-11-12 2001-08-28 Takiron Co., Ltd. Shape-memory, biodegradable and absorbable material
US6302917B1 (en) 1998-08-31 2001-10-16 Wilson-Cook Medical Incorporated Anti-reflux esophageal prosthesis
US6306163B1 (en) 1998-08-04 2001-10-23 Advanced Cardiovascular Systems, Inc. Assembly for collecting emboli and method of use
US20020002384A1 (en) 1997-11-07 2002-01-03 Paul Gilson Embolic protection device
US20020035347A1 (en) 1997-03-06 2002-03-21 Bagaoisan Celso J. Aspiration catheter
US20020035361A1 (en) 1999-06-25 2002-03-21 Houser Russell A. Apparatus and methods for treating tissue
US6365173B1 (en) 1999-01-14 2002-04-02 Efrat Biopolymers Ltd. Stereocomplex polymeric carriers for drug delivery
US6388043B1 (en) 1998-02-23 2002-05-14 Mnemoscience Gmbh Shape memory polymers
US6402687B1 (en) 1999-06-07 2002-06-11 Asahi Kogaku Kogyo Kabushiki Kaisha Fully-swallowable endoscopic system
US20020111648A1 (en) 1999-08-27 2002-08-15 Kusleika Richard S. Slideable vascular filter
US20030040804A1 (en) 2001-08-27 2003-02-27 Stack Richard S. Satiation devices and methods
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6579301B1 (en) 2000-11-17 2003-06-17 Syntheon, Llc Intragastric balloon device adapted to be repeatedly varied in volume without external assistance
US6635431B1 (en) 1997-08-06 2003-10-21 Genset, S.A. LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
WO2003094785A1 (en) 2002-05-09 2003-11-20 Egan Thomas D Gastric bypass prosthesis
US20040015187A1 (en) 2002-04-18 2004-01-22 Mnemoscience Corporation Biodegradable shape memory polymeric sutures
US6685957B1 (en) 1999-09-30 2004-02-03 Chienna B.V. Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
US20040030347A1 (en) 2002-08-07 2004-02-12 Jamy Gannoe Intra-gastric fastening devices
US20040044354A1 (en) 2002-08-30 2004-03-04 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US20040044353A1 (en) 2002-08-30 2004-03-04 James Gannoe Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
JP2004509714A (en) 2000-09-26 2004-04-02 トランスニューロニックス インコーポレイテッド Treatment methods and apparatus of obesity due to electrical stimulation of the gastrointestinal tract using a sensed activity
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US20040088022A1 (en) 2002-07-26 2004-05-06 Transneuronix, Inc. Process for electrostimulation treatment of morbid obesity
US20040092892A1 (en) 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
WO2004041133A1 (en) 2002-11-01 2004-05-21 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US6740121B2 (en) 2001-11-09 2004-05-25 Boston Scientific Corporation Intragastric stent for duodenum bypass
US20040110285A1 (en) 2000-05-31 2004-06-10 Andreas Lendlein Shape memory thermoplastics and polymer networks for tissue engineering
US20040122456A1 (en) 2002-12-11 2004-06-24 Saadat Vahid C. Methods and apparatus for gastric reduction
US20040153118A1 (en) 2003-01-30 2004-08-05 Clubb Thomas L. Embolic filters having multiple layers and controlled pore size
US6800056B2 (en) 2000-04-03 2004-10-05 Neoguide Systems, Inc. Endoscope with guiding apparatus
WO2004093753A2 (en) 2003-04-16 2004-11-04 Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method
US20040219186A1 (en) 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
US20040267378A1 (en) 2003-06-24 2004-12-30 Gazi Bashir Mussa Semi-stationary balloon in the gastric antrum provided with connecting an anchoring rod for inducing weight reduction in human beings
US20050033331A1 (en) 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050033332A1 (en) 2003-07-28 2005-02-10 Burnett Daniel R. Pyloric valve corking device and method
US20050038415A1 (en) 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
US20050049718A1 (en) 2002-11-01 2005-03-03 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20050055039A1 (en) 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20050055014A1 (en) 2003-08-04 2005-03-10 Coppeta Jonathan R. Methods for accelerated release of material from a reservoir device
US20050075622A1 (en) 2002-12-02 2005-04-07 Gi Dynamics, Inc. Bariatric sleeve
US20050075405A1 (en) 2003-10-02 2005-04-07 The Regents Of The University Of California. Shape memory polymer foams for endovascular therapies
US20050090873A1 (en) 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20050119674A1 (en) 2003-10-23 2005-06-02 Peter Gingras Gastric constriction device
US20050125020A1 (en) 2003-12-09 2005-06-09 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US20050183732A1 (en) 1999-05-18 2005-08-25 Edwards Stuart D. Surgical weight control device
US6939557B2 (en) 2000-01-28 2005-09-06 Azopax Therapeutics Llc Slow release protein polymers
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US20050238694A1 (en) 2002-07-01 2005-10-27 Gerhardt Cinderella C Satiety inducing composition
US20050245719A1 (en) 2002-10-11 2005-11-03 Mather Patrick T Shape memory polymers based on semicrystalline thermoplastic polyurethanes bearing nanostructured hard segments
US20050273060A1 (en) 2004-06-03 2005-12-08 Mayo Foundation For Medical Education And Research Obesity treatment and device
US20050277975A1 (en) 2004-06-09 2005-12-15 Usgi Medical Corp. Methods and apparatus for creating a working space within a body lumen or cavity
US20060020278A1 (en) 2003-07-28 2006-01-26 Polymorfix, Inc. Gastric retaining devices and methods
US20060064120A1 (en) 2004-09-17 2006-03-23 Levine Andy H Atraumatic gastrointestinal anchor
WO2006044640A1 (en) 2004-10-15 2006-04-27 Bfkw, Llc Bariatric device and method
US20060086362A1 (en) 2004-10-22 2006-04-27 Stephen Solomon Intestinal ablation to limit food absorption
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20060129237A1 (en) 2002-12-23 2006-06-15 Imran Mir A Stomach peristalsis device and method
US20060142794A1 (en) 2003-02-19 2006-06-29 Mnemoscience Gmbh Self-expanding device for the gastrointestinal or urogenital area
US20060155311A1 (en) 2001-05-17 2006-07-13 Kiyoshi Hashiba Intragastric device for treating obesity
US20060161139A1 (en) 2005-01-19 2006-07-20 Levine Andy H Resistive anti-obesity devices
US20060161265A1 (en) 2002-12-02 2006-07-20 Levine Andy H Bariatric sleeve
US20060161187A1 (en) 2005-01-19 2006-07-20 Gi Dynamics, Inc. Eversion resistant sleeves
US20060161172A1 (en) 2002-12-02 2006-07-20 Levine Andy H Methods of treatment using a bariatric sleeve
WO2006092789A2 (en) 2005-03-01 2006-09-08 Tulip Biotechnology Ltd. Biodegradable self-inflating intragastric implants and method of curbing appetite by the same
WO2006102240A2 (en) 2005-03-18 2006-09-28 Egan Thomas D Gastric bypass prosthesis fixation system and method for treatment of obesity
US7122058B2 (en) 2002-12-02 2006-10-17 Gi Dynamics, Inc. Anti-obesity devices
US20060247718A1 (en) 2005-04-28 2006-11-02 Medtronic, Inc. Dual mode electrical stimulation to treat obesity
US20060259051A1 (en) 2005-04-08 2006-11-16 Alveolus, Inc. Duodenum stent and associated method
US20060282107A1 (en) 2005-05-09 2006-12-14 Kiyoshi Hashiba Intragastric device for treating obesity
US20070005147A1 (en) 2005-06-08 2007-01-04 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US20070010864A1 (en) 2002-11-01 2007-01-11 Mitchell Dann Gastrointestinal implant system
WO2007030829A2 (en) 2005-09-09 2007-03-15 Biomedix, S.A. Medical device and method for controlling obesity
WO2007053706A1 (en) 2005-10-31 2007-05-10 Abdominus, Inc. Intragastric space filler
US20070110793A1 (en) 2005-11-15 2007-05-17 Kantrowitz Allen B Disintegrating digestive tract barrier
US7223277B2 (en) 2003-03-17 2007-05-29 Delegge Rebecca Method of inducing satiety
US20070135768A1 (en) 2005-12-14 2007-06-14 Carlsen Wayne D Spinal and epidural regional anesthesia catheter
US20070156159A1 (en) * 2002-10-23 2007-07-05 Jamy Gannoe Method and device for use in endoscopic organ procedures
WO2007075396A2 (en) 2005-12-15 2007-07-05 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US20070156248A1 (en) 2005-03-01 2007-07-05 Doron Marco Bioerodible self-deployable intragastric implants
US20070239284A1 (en) 2005-12-22 2007-10-11 Skerven Gregory J Coiled intragastric member for treating obesity
US20070265598A1 (en) 2004-09-30 2007-11-15 Duocure, Inc. Device and Method for Treating Weight Disorders
WO2007139920A2 (en) 2006-05-26 2007-12-06 Endosphere, Inc. Improvements in methods and devices to curb appetite and/or reduce food intake
US20070282418A1 (en) 2006-05-30 2007-12-06 Boston Scientific Scimed, Inc. Anti-obesity flow controller
US20070293885A1 (en) 2004-02-26 2007-12-20 Binmoeller Kenneth F Methods and devices to curb appetite and/or to reduce food intake
WO2008001381A2 (en) 2006-06-29 2008-01-03 Slimedics, Ltd. Gastrointestinal prostheses
US7335210B2 (en) 2002-04-03 2008-02-26 Julie Ann Smit Endoscope and tools for applying sealants and adhesives and intestinal lining for reducing food absorption
US20080065136A1 (en) 2006-08-30 2008-03-13 Andrew Young Distender device and method for treatment of obesity and metabolic and other diseases
US20080097510A1 (en) 2006-09-01 2008-04-24 Albrecht Thomas E Method for inducing weight loss with a patient
US20080234834A1 (en) 2003-12-09 2008-09-25 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
WO2009012335A1 (en) 2007-07-16 2009-01-22 Endosphere, Inc. A conformationally-stabilized intraluminal device for medical applications
US20090187206A1 (en) 2006-05-26 2009-07-23 Binmoeller Kenneth F Conformationally-Stabilized Intraluminal Device for Medical Applications
US7931693B2 (en) 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US20110137227A1 (en) 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
US20130109912A1 (en) 2011-11-01 2013-05-02 Kenneth F. Binmoeller Duodenal gastrointestinal devices and related treatment methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9300788A (en) * 1993-05-10 1994-12-01 Gen Electric Polymer blends, and articles formed therefrom.

Patent Citations (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773502A (en) 1953-12-21 1956-12-11 Arthur L Kaslow Device for treating alimentary tract
US3546961A (en) 1967-12-22 1970-12-15 Gen Electric Variable flexibility tether
US4133315A (en) 1976-12-27 1979-01-09 Berman Edward J Method and apparatus for reducing obesity
US4134405A (en) 1977-01-10 1979-01-16 Smit Julie A Catheter and intestine tube and method of using the same
US4315509A (en) 1977-01-10 1982-02-16 Smit Julie A Insertion and removal catheters and intestinal tubes for restricting absorption
US4501264A (en) 1978-06-02 1985-02-26 Rockey Arthur G Medical sleeve
US4416267A (en) 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4899747A (en) 1981-12-10 1990-02-13 Garren Lloyd R Method and appartus for treating obesity
US4485805A (en) 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
JPH0115063B2 (en) 1983-12-09 1989-03-15 Hitachi Metals Ltd
US4648383A (en) 1985-01-11 1987-03-10 Angelchik Jean P Peroral apparatus for morbid obesity treatment
US4694827A (en) 1986-01-14 1987-09-22 Weiner Brian C Inflatable gastric device for treating obesity and method of using the same
US4878905A (en) 1986-02-07 1989-11-07 Blass Karl G Gastrointestinal module: a nonsurgical implant
WO1989000407A1 (en) 1987-07-21 1989-01-26 Thomas Vincent Taylor Apparatus for arrest of bleeding at a duodenal ulcer
US5084061A (en) 1987-09-25 1992-01-28 Gau Fred C Intragastric balloon with improved valve locating means
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
DE4012642A1 (en) 1990-04-20 1991-10-24 Wolf Gmbh Richard Therapy or surgical instrument - has pre-shaped balloons of different sizes inflated via endoscope etc.
US5597797A (en) 1990-06-07 1997-01-28 Genentech, Inc. Method for treatment or prevention of obesity
US5329942A (en) 1990-08-14 1994-07-19 Cook, Incorporated Method for filtering blood in a blood vessel of a patient
US5484610A (en) 1991-01-02 1996-01-16 Macromed, Inc. pH and temperature sensitive terpolymers for oral drug delivery
US5234454A (en) 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
US5259399A (en) 1992-03-02 1993-11-09 Alan Brown Device and method of causing weight loss using removable variable volume intragastric bladder
US5396880A (en) 1992-04-08 1995-03-14 Danek Medical, Inc. Endoscope for direct visualization of the spine and epidural space
US6267988B1 (en) 1992-05-28 2001-07-31 James H. Meyer Composition and method for inducing satiety
US5439476A (en) 1993-02-04 1995-08-08 Trigonon, Inc. Inflatable laparoscopic retractor
US6102922A (en) 1995-09-22 2000-08-15 Kirk Promotions Limited Surgical method and device for reducing the food intake of patient
US20020035347A1 (en) 1997-03-06 2002-03-21 Bagaoisan Celso J. Aspiration catheter
US5868141A (en) 1997-05-14 1999-02-09 Ellias; Yakub A. Endoscopic stomach insert for treating obesity and method for use
US6635431B1 (en) 1997-08-06 2003-10-21 Genset, S.A. LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
US5820584A (en) 1997-08-28 1998-10-13 Crabb; Jerry A. Duodenal insert and method of use
US20020002384A1 (en) 1997-11-07 2002-01-03 Paul Gilson Embolic protection device
US6336934B1 (en) 1997-11-07 2002-01-08 Salviac Limited Embolic protection device
US6187330B1 (en) 1998-01-30 2001-02-13 Scios Inc. Controlled release delivery of peptide or protein
US6160084A (en) 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6720402B2 (en) 1998-02-23 2004-04-13 Mnemoscience Gmbh Shape memory polymers
US6388043B1 (en) 1998-02-23 2002-05-14 Mnemoscience Gmbh Shape memory polymers
US6306163B1 (en) 1998-08-04 2001-10-23 Advanced Cardiovascular Systems, Inc. Assembly for collecting emboli and method of use
US6264700B1 (en) 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve
US6302917B1 (en) 1998-08-31 2001-10-16 Wilson-Cook Medical Incorporated Anti-reflux esophageal prosthesis
US6281262B1 (en) 1998-11-12 2001-08-28 Takiron Co., Ltd. Shape-memory, biodegradable and absorbable material
US6365173B1 (en) 1999-01-14 2002-04-02 Efrat Biopolymers Ltd. Stereocomplex polymeric carriers for drug delivery
US20050183732A1 (en) 1999-05-18 2005-08-25 Edwards Stuart D. Surgical weight control device
US6402687B1 (en) 1999-06-07 2002-06-11 Asahi Kogaku Kogyo Kabushiki Kaisha Fully-swallowable endoscopic system
US20020035361A1 (en) 1999-06-25 2002-03-21 Houser Russell A. Apparatus and methods for treating tissue
US20020111648A1 (en) 1999-08-27 2002-08-15 Kusleika Richard S. Slideable vascular filter
US6685957B1 (en) 1999-09-30 2004-02-03 Chienna B.V. Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
US6939557B2 (en) 2000-01-28 2005-09-06 Azopax Therapeutics Llc Slow release protein polymers
US6800056B2 (en) 2000-04-03 2004-10-05 Neoguide Systems, Inc. Endoscope with guiding apparatus
US20040110285A1 (en) 2000-05-31 2004-06-10 Andreas Lendlein Shape memory thermoplastics and polymer networks for tissue engineering
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
JP2004509714A (en) 2000-09-26 2004-04-02 トランスニューロニックス インコーポレイテッド Treatment methods and apparatus of obesity due to electrical stimulation of the gastrointestinal tract using a sensed activity
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6579301B1 (en) 2000-11-17 2003-06-17 Syntheon, Llc Intragastric balloon device adapted to be repeatedly varied in volume without external assistance
US20060155311A1 (en) 2001-05-17 2006-07-13 Kiyoshi Hashiba Intragastric device for treating obesity
US20040219186A1 (en) 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
US7121283B2 (en) 2001-08-27 2006-10-17 Synecor, Llc Satiation devices and methods
US20030040804A1 (en) 2001-08-27 2003-02-27 Stack Richard S. Satiation devices and methods
US20050004681A1 (en) 2001-08-27 2005-01-06 Stack Richard S. Satiation devices and methods
US20030199990A1 (en) 2001-08-27 2003-10-23 Stack Richard S. Satiation devices and methods
US7111627B2 (en) 2001-08-27 2006-09-26 Synecor, Llc Satiation devices and methods
US7175669B2 (en) 2001-11-09 2007-02-13 Boston Scientific Corporation Intragastric stent for duodenum bypass
US6946002B2 (en) 2001-11-09 2005-09-20 Boston Scientific Corporation Intragastric stent for duodenum bypass
US6740121B2 (en) 2001-11-09 2004-05-25 Boston Scientific Corporation Intragastric stent for duodenum bypass
US7335210B2 (en) 2002-04-03 2008-02-26 Julie Ann Smit Endoscope and tools for applying sealants and adhesives and intestinal lining for reducing food absorption
US20040015187A1 (en) 2002-04-18 2004-01-22 Mnemoscience Corporation Biodegradable shape memory polymeric sutures
WO2003094785A1 (en) 2002-05-09 2003-11-20 Egan Thomas D Gastric bypass prosthesis
US20050238694A1 (en) 2002-07-01 2005-10-27 Gerhardt Cinderella C Satiety inducing composition
US20040088022A1 (en) 2002-07-26 2004-05-06 Transneuronix, Inc. Process for electrostimulation treatment of morbid obesity
US20040030347A1 (en) 2002-08-07 2004-02-12 Jamy Gannoe Intra-gastric fastening devices
US20040044353A1 (en) 2002-08-30 2004-03-04 James Gannoe Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US20040044354A1 (en) 2002-08-30 2004-03-04 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US20050245719A1 (en) 2002-10-11 2005-11-03 Mather Patrick T Shape memory polymers based on semicrystalline thermoplastic polyurethanes bearing nanostructured hard segments
US20070156159A1 (en) * 2002-10-23 2007-07-05 Jamy Gannoe Method and device for use in endoscopic organ procedures
US20070010865A1 (en) 2002-11-01 2007-01-11 Mitchell Dann Everting gastrointestinal sleeve
US20050049718A1 (en) 2002-11-01 2005-03-03 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20040092892A1 (en) 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
WO2004041133A1 (en) 2002-11-01 2004-05-21 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US20070010864A1 (en) 2002-11-01 2007-01-11 Mitchell Dann Gastrointestinal implant system
US20070027548A1 (en) 2002-12-02 2007-02-01 Levine Andy H Anti-obesity devices
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US20070083271A1 (en) 2002-12-02 2007-04-12 Levine Andy H Anti-obesity devices
US7122058B2 (en) 2002-12-02 2006-10-17 Gi Dynamics, Inc. Anti-obesity devices
US20060161265A1 (en) 2002-12-02 2006-07-20 Levine Andy H Bariatric sleeve
US20050080395A1 (en) 2002-12-02 2005-04-14 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US20050080431A1 (en) 2002-12-02 2005-04-14 Gi Dynamics, Inc. Bariatric sleeve removal devices
US20050080491A1 (en) 2002-12-02 2005-04-14 Gi Dynamics, Inc. Bariatric sleeve delivery devices
US20050075622A1 (en) 2002-12-02 2005-04-07 Gi Dynamics, Inc. Bariatric sleeve
US20060161172A1 (en) 2002-12-02 2006-07-20 Levine Andy H Methods of treatment using a bariatric sleeve
US20040122456A1 (en) 2002-12-11 2004-06-24 Saadat Vahid C. Methods and apparatus for gastric reduction
US20060129237A1 (en) 2002-12-23 2006-06-15 Imran Mir A Stomach peristalsis device and method
US20040153118A1 (en) 2003-01-30 2004-08-05 Clubb Thomas L. Embolic filters having multiple layers and controlled pore size
US20060142794A1 (en) 2003-02-19 2006-06-29 Mnemoscience Gmbh Self-expanding device for the gastrointestinal or urogenital area
US7223277B2 (en) 2003-03-17 2007-05-29 Delegge Rebecca Method of inducing satiety
WO2004093753A2 (en) 2003-04-16 2004-11-04 Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method
US20040267378A1 (en) 2003-06-24 2004-12-30 Gazi Bashir Mussa Semi-stationary balloon in the gastric antrum provided with connecting an anchoring rod for inducing weight reduction in human beings
US20050033331A1 (en) 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050055039A1 (en) 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20060020278A1 (en) 2003-07-28 2006-01-26 Polymorfix, Inc. Gastric retaining devices and methods
US20050033332A1 (en) 2003-07-28 2005-02-10 Burnett Daniel R. Pyloric valve corking device and method
US20050055014A1 (en) 2003-08-04 2005-03-10 Coppeta Jonathan R. Methods for accelerated release of material from a reservoir device
US20050038415A1 (en) 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
US20050075405A1 (en) 2003-10-02 2005-04-07 The Regents Of The University Of California. Shape memory polymer foams for endovascular therapies
US20060079944A1 (en) 2003-10-22 2006-04-13 Imran Mir A Device and method for treating obesity
US20050090873A1 (en) 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20050119674A1 (en) 2003-10-23 2005-06-02 Peter Gingras Gastric constriction device
US20080234834A1 (en) 2003-12-09 2008-09-25 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US20060265082A1 (en) 2003-12-09 2006-11-23 Meade John C Intestinal sleeve
US20050125020A1 (en) 2003-12-09 2005-06-09 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US20050125075A1 (en) 2003-12-09 2005-06-09 Gi Dynamics, Inc. Intestinal sleeve
US20120172999A1 (en) 2004-02-26 2012-07-05 Binmoeller Kenneth F Methods and devices to curb appetite and/or reduce food intake
US8147561B2 (en) * 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US20140100513A1 (en) 2004-02-26 2014-04-10 Kenneth F. Binmoeller Method and apparatus for reducing obesity
US20070293885A1 (en) 2004-02-26 2007-12-20 Binmoeller Kenneth F Methods and devices to curb appetite and/or to reduce food intake
US7931693B2 (en) 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US20140114228A1 (en) 2004-02-26 2014-04-24 Kenneth F. Binmoeller Methods and devices to curb appetite and/or to reduce food intake
US20110190684A1 (en) 2004-02-26 2011-08-04 Binmoeller Kenneth F Method and apparatus for reducing obesity
US20050273060A1 (en) 2004-06-03 2005-12-08 Mayo Foundation For Medical Education And Research Obesity treatment and device
WO2005120363A1 (en) 2004-06-03 2005-12-22 Mayo Foundation For Medical Education And Research Obesity treatment and device
US20050277975A1 (en) 2004-06-09 2005-12-15 Usgi Medical Corp. Methods and apparatus for creating a working space within a body lumen or cavity
US20060064120A1 (en) 2004-09-17 2006-03-23 Levine Andy H Atraumatic gastrointestinal anchor
US20070265598A1 (en) 2004-09-30 2007-11-15 Duocure, Inc. Device and Method for Treating Weight Disorders
WO2006044640A1 (en) 2004-10-15 2006-04-27 Bfkw, Llc Bariatric device and method
US20060086362A1 (en) 2004-10-22 2006-04-27 Stephen Solomon Intestinal ablation to limit food absorption
US20060161139A1 (en) 2005-01-19 2006-07-20 Levine Andy H Resistive anti-obesity devices
US20060161187A1 (en) 2005-01-19 2006-07-20 Gi Dynamics, Inc. Eversion resistant sleeves
WO2006092789A2 (en) 2005-03-01 2006-09-08 Tulip Biotechnology Ltd. Biodegradable self-inflating intragastric implants and method of curbing appetite by the same
US20070156248A1 (en) 2005-03-01 2007-07-05 Doron Marco Bioerodible self-deployable intragastric implants
WO2006102240A2 (en) 2005-03-18 2006-09-28 Egan Thomas D Gastric bypass prosthesis fixation system and method for treatment of obesity
US20060259051A1 (en) 2005-04-08 2006-11-16 Alveolus, Inc. Duodenum stent and associated method
US20060247718A1 (en) 2005-04-28 2006-11-02 Medtronic, Inc. Dual mode electrical stimulation to treat obesity
US20060282107A1 (en) 2005-05-09 2006-12-14 Kiyoshi Hashiba Intragastric device for treating obesity
US20070005147A1 (en) 2005-06-08 2007-01-04 Gi Dynamics, Inc. Gastrointestinal anchor compliance
WO2007030829A2 (en) 2005-09-09 2007-03-15 Biomedix, S.A. Medical device and method for controlling obesity
WO2007053706A1 (en) 2005-10-31 2007-05-10 Abdominus, Inc. Intragastric space filler
WO2007053707A1 (en) 2005-10-31 2007-05-10 Abdominus, Inc. Intragastric space filler
WO2007053556A1 (en) 2005-10-31 2007-05-10 Abdominus, Inc. Intragastric space filler
US20070110793A1 (en) 2005-11-15 2007-05-17 Kantrowitz Allen B Disintegrating digestive tract barrier
US20070135768A1 (en) 2005-12-14 2007-06-14 Carlsen Wayne D Spinal and epidural regional anesthesia catheter
WO2007075396A2 (en) 2005-12-15 2007-07-05 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US20070239284A1 (en) 2005-12-22 2007-10-11 Skerven Gregory J Coiled intragastric member for treating obesity
WO2007139920A2 (en) 2006-05-26 2007-12-06 Endosphere, Inc. Improvements in methods and devices to curb appetite and/or reduce food intake
US20090187206A1 (en) 2006-05-26 2009-07-23 Binmoeller Kenneth F Conformationally-Stabilized Intraluminal Device for Medical Applications
US20070282418A1 (en) 2006-05-30 2007-12-06 Boston Scientific Scimed, Inc. Anti-obesity flow controller
WO2008001381A2 (en) 2006-06-29 2008-01-03 Slimedics, Ltd. Gastrointestinal prostheses
US20080065136A1 (en) 2006-08-30 2008-03-13 Andrew Young Distender device and method for treatment of obesity and metabolic and other diseases
US20080097510A1 (en) 2006-09-01 2008-04-24 Albrecht Thomas E Method for inducing weight loss with a patient
WO2009012335A1 (en) 2007-07-16 2009-01-22 Endosphere, Inc. A conformationally-stabilized intraluminal device for medical applications
US20110137227A1 (en) 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
US20130109912A1 (en) 2011-11-01 2013-05-02 Kenneth F. Binmoeller Duodenal gastrointestinal devices and related treatment methods

Non-Patent Citations (50)

* Cited by examiner, † Cited by third party
Title
Asakawa et al., "Characterization of the effects of pancreatic polypeptide in the regulation of energy balance," Gastroenterology 124(5):1325-36 (May 2003).
Batterham et al., "Gut hormone PYY(3-36) physiologically inhibits food intake," Nature 418(6898): 650-4 (Aug. 8, 2002).
Batterham et al., "Inhibition of food intake in obese subjects by peptide YY3-36," 0N Engl J Med., 349(10):941-8 (Sep. 4, 2003).
Batterham et al., "Pancreatic polypeptide reduces appetite and food intake in humans," J Clin Endocrinol Metab. 88(8):3989-92 (Aug. 2003).
Binmoeller, K.; U.S. Appl. No. 13/768,659 entitled "Methods and devices to curb appetite and/or reduce food intake," filed Feb. 15, 2013.
Burnett, Daniel R.; U.S. Appl. No. 60/490,421 entitled "Pyloric valve corking device and method," filed Jul. 28, 2003.
Burnett, Daniel R.; U.S. Appl. No. 60/525,105 entitled "Intragastric therapeutic device and method," filed Nov. 28, 2003.
Caro et al., "Leptin: the tale of an obesity gene," Diabetes 45(11): 1455-62 (Nov. 1996).
Chapman et al., "Effects of small-intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men," Am J Clin Nutr, vol. 69, pp. 6-12 (Jan. 1999).
Cohen et al., "Oxyntomodulin suppresses appetite and reduces food intake in humans," J Clin Endocrinol Metab., 88(10): 4696-4701 (Oct. 2003).
Collins et al., "Role of leptin in fat regulation," Nature, 380 (6576):677 (Apr. 25, 1996).
D'Alessio et al., "Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques," J Clin Endocrinol Metab., 86(3): 1253-9 (Mar. 2001).
Davis et al., "Distension of the small intestine, satiety, and the control of food intake," Am Journal of Clinical Nutrition, vol. 31, pp. S255-S258 (Oct. 1978).
de Castro et al., "A general model of intake regulation," Neuroscience and Biobehavioral Reviews, vol. 26(5), pp. 581-595 (Aug. 2002).
French et al.,"Is Cholecystokinin a Satiety Hormone? Correlations of Plasma Cholecystokinin with Hunger, Satiety, and Gastric Empyting in Normal Volunteers," Appetite, vol. 16, pp. 95-104 (Oct. 1993).
Gao et al., "Sensory and biomechanical responses to ramp-controlled distension of the human duodenum," Am. J. Physiol. Gas., vol. 284, pp. G461-G471 (Mar. 2003).
Geliebter et al., "Clinical trial of silicone rubber gastric balloon to treat obesity," Int J Obesity, 15(4): 259-266 (Apr. 1991).
Ghatei et al., Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract, J Clin Endocrinol Metab, 57(3):488-95 (Sep. 1983).
Gibbs et al., "Cholecystokinin descreases food intake in rats," J Comp Physiol Psychol. 84(3):488-95 (Sep. 1973).
Havel, Peter, "Peripheral signals conveying metabolic information to the brain: Short-term and long-term regulation of food intake and energy homeostasis," Society for Experimental Biology and Medicine, vol. 226, pp. 963-977 (Dec 2001).
Havel, PJ, "Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance," Proc Nutr Soc. 59(3):359-71 (Aug. 2000).
Haynes et al., "Receptor-mediated regional sympathetic nerve activation by leptin," J Clin Invest. 100(2): 270-278 (Jul. 15, 1997).
Herrmann et al., "Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients," Digestion 56(2);117-26; (year of publication is sufficiently earlier than the effective U.S. filing and any foreign priority date ) 1995.
Kissileff et al., "Peptides that Regulate Food Intake: Cholecystokinin and stomach distension combine to reduce food intake in humans," Am J Physiol Regul Integr Comp Physiol., 285(5):R992-8 (Nov. 2003).
Le Quellec et al., "Oxyntomodulin-like immunoreactivity: diurnal profile of a new potential entergastrone," J Clin Endocrinol Metab, 74(6): 1405-9 (Jun. 1992).
Levin et al., "Decreased food intake does not completely account for adiposity reduction after ob protein infusion," Proc Natl Acad Sci U.S.A., 93(4): 1726-30 (Feb. 20, 1996).
Liddle et al., "Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction," J Clin Invest. 75(4):1144-52 (Apr. 1985).
Lindor et al., "Intragastric balloons in comparison with standard therapy for obesity-a randomized, double-blind trial," Mayo Clin Proc 62(11): 992-6 (Nov. 1987).
Malaisse-Lagae et al., "Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. (Hypothesis)" Experientia 15; 33(7):915-917 (Jul. 15, 1977).
Mathus-Vliegen et al., "Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-millimeter balloon," Gastroenterology, 99(2): 362-369 (Aug. 1990).
Moran el al, "Neurobiology of cholecystokinin," Crit Rev Neurobiol. 9(1): 1-28 (year of publication is sufficiently earlier than the effective U.S. filing and any foreign priority date) 1994.
Moran et al., "Gastrointestinal satiety signals," Am J Physiol Gastrointest Liver Physiol, vol. 286, pp. G183-G188 (Feb. 1, 2004).
Näslund et al., "GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans," Am J Physiol 277 (3 Pt 2):R910-R916 (Sep. 1999).
Rayner et al., "Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycermia," Am J. Physiol. Gastrointest. Liver Physiol. , vol. 278, pp. G98-G104 (Jan. 2000).
Read et al., "The Role of the Gut in Regulating Food Intake in Man," Nutrition Reviews, vol. 52, pp. 1-10 (Jan. 1994).
Read, N.W. "Role of gastrointestinal factors in hunger and satiety in man," Proceedings of the Nutrition Society, vol. 51, pp. 7-11 (May 1992).
Remington: The Science and Practice of Pharmacy, 20th Ed., Chap. 47, Controlled Release Drug Delivery Systems. (Jun. 2003).
Remington's Pharmaceutical Sciences, 17th Ed.; A. R. Gennaro (Editor); "Freeze-drying," p. 1538-1539 (year of publication is sufficiently earlier than the effective U.S. filing and any foreign priority date) 1985.
Rigaud et al., "Gastric distension, hunger, and energy intake after balloon implantation in severe obesity," Int J Obes Relat Metab Disor., 19(7):489-95 (Jul. 1995).
Ritter, Robert C.; Gastrointestinal mechanisms of satiation for food; Physiol Behav.; 81(2):249-73; Apr. 2004.
Scarpace et al., "Leptin increases uncoupling protein expression and energy expenditure," Am J Physiol., 273 (1 Pt 1): E226-230 (Jul. 1997).
Schirra et al., Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1 (7-36)amide in non-insulin dependent diabetes mellitus, J Endocrinol. 156(1):177-86 (Jan. 1998).
Schwartz et al., "Central nervous system control of food intake," Nature, 404(6778): 661-671 (Apr. 6, 2000).
Schwartz et al., "Keeping hunger at bay," Nature, vol. 418, pp. 595-597; Aug. 8, 2002.
Schwartz et al., "Model for the regulation of energy balance and adiposity by the central nervous system," Am J Clin Nutr., 69(4): 584-96 (Apr. 1999).
Standring, Susan (ed). Gray's Anatomy, 39th Ed. 1163-64; Nov. 24, 2004.
Wang et al.; Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production; Nature; vol. 452; pp. 1012-1016 (Apr. 24, 2008).
Wilding, J. P. H., "Neuropeptides and appetite control," Diabetes U.K. Diabetic Medicine, vol. 19, pp. 619-627 (Aug. 2002).
Woods et al., "The Regulation of Food Intake by Peptides," Annals of the New York Academy of Sciences, vol. 575. pp. 236-243; Dec. 1989.
Wynne et al., "Appetite control," Journal of Endocrinology, vol. 184, pp. 291-318; Feb. 2005.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140114228A1 (en) * 2004-02-26 2014-04-24 Kenneth F. Binmoeller Methods and devices to curb appetite and/or to reduce food intake
US20150305906A1 (en) * 2004-11-30 2015-10-29 James T. McKinley Methods and devices for delivering or delaying lipids within a duodenum
US20170156908A1 (en) * 2004-11-30 2017-06-08 James T. McKinley Methods and devices for delivering or delaying lipids within a duodenum

Also Published As

Publication number Publication date Type
US20130178782A1 (en) 2013-07-11 application
US20150305906A1 (en) 2015-10-29 application
US20170156908A1 (en) 2017-06-08 application
US20110137227A1 (en) 2011-06-09 application

Similar Documents

Publication Publication Date Title
US8070768B2 (en) Devices and methods for treatment of obesity
US7881797B2 (en) Methods and devices for gastrointestinal stimulation
US20050022827A1 (en) Method and device for gastrointestinal bypass
US7803195B2 (en) Obesity treatment and device
US20050256587A1 (en) Gastric bypass prosthesis
US20050192614A1 (en) Method and apparatus for reducing obesity
US20060106332A1 (en) Pancreatic exocrine secretion diversion apparatus and method
US8029455B2 (en) Satiation pouches and methods of use
US20070282453A1 (en) Anti-obesity stent
US7846138B2 (en) Cuff and sleeve system for gastrointestinal bypass
US7837669B2 (en) Devices and methods for endolumenal gastrointestinal bypass
US7146984B2 (en) Method and apparatus for modifying the exit orifice of a satiation pouch
US6939374B2 (en) Stents, stenting systems, and related methods for agent delivery
US20060178691A1 (en) Methods and devices to curb appetite and/or reduce food intake
US20070233188A1 (en) Adhesives for use with suture system minimize tissue erosion
US20080195226A1 (en) Intestinal sleeves and associated deployment systems and methods
US20080039878A1 (en) Systems and methods for restoring function of diseased bowel
US7615064B2 (en) Endolumenal gastric ring with suspended impeding member
US20080065136A1 (en) Distender device and method for treatment of obesity and metabolic and other diseases
US20110046537A1 (en) Systems and Methods for Treatment of Obesity and Type 2 Diabetes
US7220284B2 (en) Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20010039414A1 (en) Sustained release delivery systems for solutes
US20080065122A1 (en) Restrictive and/or obstructive implant system for inducing weight loss
US20090312597A1 (en) Methods and devices for limiting gastric expansion
US20090187206A1 (en) Conformationally-Stabilized Intraluminal Device for Medical Applications

Legal Events

Date Code Title Description
AS Assignment

Owner name: ENDOSPHERE, INC., OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCKINLEY, JAMES T.;KECK, ZHENYONG;SANDER, FIONA M.;SIGNING DATES FROM 20110122 TO 20110123;REEL/FRAME:030953/0480

CC Certificate of correction